- Home
- MEDP
as 11-15-2024 3:37pm EST
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the us, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
| Founded: | 1992 | Country: | United States |
| Employees: | N/A | City: | CINCINNATI |
| Market Cap: | 11.7B | IPO Year: | 2016 |
| Target Price: | $388.44 | AVG Volume (30 days): | 442.3K |
| Analyst Decision: | Buy | Number of Analysts: | 10 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 11.42 | EPS Growth: | 33.84 |
| 52 Week Low/High: | $268.80 - $459.77 | Next Earning Date: | 10-21-2024 |
| Revenue: | $2,070,866,000 | Revenue Growth: | 16.24% |
| Revenue Growth (this year): | 14.01% | Revenue Growth (next year): | 5.86% |
Stock Insider Trading Activity of Medpace Holdings Inc. (MEDP)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Kraft Robert O. | MEDP | Director | Aug 22 '24 | Sell | $390.73 | 8,127 | $3,175,462.71 | 520 |
Latest Medpace Holdings Inc. News
MEDP Breaking Stock News: Dive into MEDP Ticker-Specific Updates for Smart Investing
Morningstar Research
2 days ago
Analyst Report: Medpace Holdings, Inc.
Argus Research
5 days ago
MEDP: Raising target price to $379.00
Simply Wall St.
10 days ago
When Should You Buy Medpace Holdings, Inc. (NASDAQ:MEDP)?
Morningstar Research
11 days ago
Analyst Report: Medpace Holdings, Inc.
Argus Research
12 days ago
MEDP: Lowering target price to $345.00
Insider Monkey
13 days ago
What Makes Medpace Holdings (MEDP) a Good Holding?
MT Newswires
25 days ago
Baird Downgrades Medpace to Neutral From Outperform, Adjusts Price Target to $349 From $413
Thomson Reuters StreetEvents
a month ago
Q3 2024 Medpace Holdings Inc Earnings Call
Compare MEDP vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "MEDP Medpace Holdings Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.